You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Metro

FDA quietly steps in to inspect a second Mass. pharmacy

Agency expands actions amid inquiries by state

Federal regulators have quiet­ly stepped in to inspect another Massachusetts pharmacy similar to New England Compounding Center, the Framingham company blamed for the national fungal meningitis outbreak that sickened more than 660 people and killed 40.

Food and Drug Administration workers recently joined state officials, who have been conducting surprise inspections of compounders, to inspect one pharmacy because regulators determined the company’s actions fell under federal jurisdiction, Dr. Madeleine ­Biondolillo, director of the state’s Bureau of Health Care Safety and Quality, said in an interview Tuesday.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week